Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK8 | P45983 | 1/20 | 0.47 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.47 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.47 |
| ▸ | VIPR1 | P32241 | 2/20 | 0.44 |
| ▸ | CXCR4 | P61073 | 1/20 | 0.43 |
| ▸ | OPRL1 | P41146 | 3/20 | 0.43 |
| ▸ | ECE1 | P42892 | 1/20 | 0.43 |
| ▸ | GLP1R | P43220 | 1/20 | 0.43 |
| ▸ | MUS81 | Q96NY9 | 1/20 | 0.43 |
| ▸ | VIPR2 | P41587 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30774306 | 0.93 | OPRL1 (0.43) | MAPK8MAPK9MAPK10OPRL1ECE1 | |
| SCHEMBL29374718 | 0.89 | TFPI (0.44) | CXCR4 | |
| SCHEMBL31236827 | 0.86 | IL23R (0.42) | MAPK8MAPK9MAPK10CXCR4 | |
| SCHEMBL30006921 | 0.86 | OPRL1 (0.49) | CXCR4OPRL1 | |
| SCHEMBL31688348 | 0.86 | VIPR1 (0.45) | MAPK8MAPK9MAPK10VIPR1ECE1 | |
| SCHEMBL30880884 | 0.85 | VIPR1 (0.46) | MAPK8MAPK9MAPK10VIPR1ECE1 | |
| SCHEMBL31688351 | 0.85 | GLP1R (0.43) | VIPR1ECE1GLP1RMUS81VIPR2 | |
| SCHEMBL29375236 | 0.84 | TFPI (0.43) | — | |
| SCHEMBL30293065 | 0.83 | ENPEP (0.45) | OPRL1 | |
| SCHEMBL29940601 | 0.83 | IL23R (0.46) | CXCR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220324950-A1 | IMMUNE CHECKPOINT INHIBITOR, THERAPEUTIC AGENT FOR IMMUNE CHECKPOINT-RELATED DISEASE, IMMUNOSUPPRESSANT, ANTI-FIBRONECTIN ANTIBODY OR DERIVATIVE THEREOF, FIBRONECTIN ANALOG, KIT FOR DETECTING FIBRONECTIN OR PARTIAL PROTEIN THEREOF, AND METHOD FOR DETECTING FIBRONECTIN OR PARTIAL PROTEIN THEREOF | TOHOKU TECHNO ARCH CO., LTD. (JP) | 2022-10-13 | — | — | US | disclosed |
| EP-4014994-A1 | IMMUNE CHECKPOINT INHIBITOR, THERAPEUTIC AGENT FOR IMMUNE CHECKPOINT-RELATED DISEASE, IMMUNOSUPPRESSANT, ANTI-FIBRONECTIN ANTIBODY OR DERIVATIVE THEREOF, FIBRONECTIN ANALOG, KIT FOR DETECTING FIBRONECTIN OR PARTIAL PROTEIN THEREOF, AND METHOD FOR DETECTING FIBRONECTIN OR PARTIAL PROTEIN THEREOF | Tohoku University (JP) | 2022-06-22 | — | — | EP | disclosed |